The record → All 128 providers → Mochi Health
Provider Dossier · joinmochi.com · Last verified 16 November 2026
Is Mochi Health legit?
Quick answerLast verified · GLP-1 Dossier Editorial Desk
Our enforcement sweep matched 3 primary-sourced regulatory or legal actions on file involving Mochi Health (joinmochi.com), each linked to the original document below.
Published prices start at $79/mo; that figure is a membership or consultation fee, with medication billed separately.
It offers both compounded and FDA-approved GLP-1 options.
Disclosure: Unmonetized direct link (Mochi Health has no commercial relationship with this site).
Yes, Mochi Health (joinmochi.com) is a real, operating US telehealth company that ships prescriptions, not a counterfeit card-skimming site. However, our enforcement sweep matched 3 primary-sourced regulatory or legal actions on file involving the company, each linked to the original government or court document below.
On the clinical side, Mochi Health offers both compounded and FDA-approved GLP-1 options at sharply different price tiers, and its published plan starts at $49 for the first month before renewing at $79/mo (medication billed separately). Disclosed or linked fulfillment pharmacies in our record include Aequita Pharmacy.
Comparing Mochi Health against compounded and branded providers with 0 actions on file
Mochi Health has 3 regulatory or legal actions documented below. For readers comparing transparent options in the same supply category before entering payment details, these providers have 0 actions on file and published monthly pricing:
- Website & Terms inspected
- joinmochi.com (Direct checkout & Terms of Service verified)
- Last price & terms read
- 16 November 2026 (Separate membership fee + medication billed on top)
- 503A / 503B pharmacy disclosure
- Aequita Pharmacy (named in public terms, intake disclosures, or primary filings)
- Public registries searched
- FDA CDER Warning Letters (2024–2026), Federal District Court Dockets (PACER / CourtListener), FTC Enforcement Actions, NAD Case Reports → 3 primary document linked belows
- Researcher field note
- Operated by Mochi Health Corp. (joinmochi.com). Compounded semaglutide is $99/month ($60/month on select multi-month promos) and compounded tirzepatide is $199/month ($90/month on select promos) billed on top of the mandatory $79/month membership ($139–$178/month combined floor). Mochi faces a December 2024 Eli Lilly federal lawsuit (3:24-cv-09313) alleging it routed prescriptions through tiny-volume compounder Aequita Pharmacy and added unstudied vitamins to claim personalized dosing, and Washington State DOH restricted Aequita Pharmacy’s license in March 2025 over sterile compounding violations. No FDA warning letter directly naming Mochi Health Corp. was found.
What it actually supplies
Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to.
Named on its own site (joinmochi.com): compounded semaglutide, compounded tirzepatide, Zepbound, Mounjaro.
Disclosed fulfillment / 503A / 503B pharmacies on record: Aequita Pharmacy (see the full 503A/503B pharmacy & compounding tracker).
What regulators and courts have said
Every entry below links to its original document and identifies the source type. We publish what the official record states and nothing beyond it; a regulatory letter or lawsuit involving a company is not proof that an individual patient was harmed.
April 2025
Eli Lilly sued Mochi Health Corp. in the Northern District of California on 23 April 2025 (No. 3:25-cv-03534) over compounded tirzepatide combined with additives including niacinamide, pyridoxine and glycine. In October 2025 the court granted Mochi's motion to dismiss with leave to amend, holding Lilly had not established standing on reputational harm alone.
August 2025
Novo Nordisk sued Mochi Health Corp. and its affiliated medical practices in the Northern District of California on 4 August 2025 (No. 5:25-cv-06563), alleging false advertising and unlawful mass compounding of semaglutide, including converting standard doses to non-standard ones and adding vitamin B12; allegations unproven.
March 2025
The Washington State Pharmacy Quality Assurance Commission issued a Limited Stop Service order on 13 March 2025 against Aequita Pharmacy LLC of Kirkland, Washington — reported to compound for Mochi Health — barring it from compounding or dispensing compounded products in the state, citing untrained and unqualified staff performing sterile compounding, inadequate supervision, and failure to follow sterile compounding procedures.
Other signals on file
Not regulatory or legal actions, and never counted as such. We log these items separately because they are sourced and relevant to prospective patients (complaint volumes, corporate and pharmacy disclosures, third-party lab reports, or commercial disputes).
BBB rating A but not accredited, with 1,378 complaints; themes include membership and medication subscriptions having to be cancelled separately, charges continuing after cancellation, and medication arriving heat-damaged.
Corporate entity, pricing & cancellation terms
Operated by Mochi Health Corp. (joinmochi.com). Compounded semaglutide is $99/month ($60/month on select multi-month promos) and compounded tirzepatide is $199/month ($90/month on select promos) billed on top of the mandatory $79/month membership ($139–$178/month combined floor). Mochi faces a December 2024 Eli Lilly federal lawsuit (3:24-cv-09313) alleging it routed prescriptions through tiny-volume compounder Aequita Pharmacy and added unstudied vitamins to claim personalized dosing, and Washington State DOH restricted Aequita Pharmacy’s license in March 2025 over sterile compounding violations. No FDA warning letter directly naming Mochi Health Corp. was found.
Go direct
The button below is a plain direct link to Mochi Health and earns us nothing. Mochi Health has no commercial arrangement with this desk and is documented under the exact same verification rules as companies that do pay.
Visit Mochi Health (joinmochi.com) →Lower advertised starting prices
Providers advertising a lower monthly entry figure. Check each dossier before comparing two numbers: the headline price alone does not tell you whether medication is included.
If you prefer FDA-approved medication only
These clinics prescribe FDA-approved brand-name drugs only and currently have 0 regulatory actions on file here.
Side-by-side records
Compared with the alternatives
Direct dossier comparisons for the providers patients most frequently weigh against Mochi Health.
Long-form provider files
Full price tables, terms and records
Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.
| Provider file | Sema. /mo | Tirz. /mo | Actions on file | Links |
|---|---|---|---|---|
| Embody | $49 | $99 | None | Read the dossier →Embody site ↗ |
| Belle | $93 | $149 | 1 | Read the dossier →Belle site ↗ |
| PlexusDx | $99 | $129 | None | Read the dossier →PlexusDx site ↗ |
| MEDGm | $169 | $269 | None | Read the dossier →MEDGm site ↗ |
| DirectMeds | $249 | $399 | 1 | Read the dossier →DirectMeds site ↗ |
| GoodLife Health | $299 membership | + brand-name drug | None | Read the dossier →GoodLife Health site ↗ |
- Embodyfrom $49/moSema. $49 · Tirz. $99None on file
- Bellefrom $93/moSema. $93 · Tirz. $1491 on file
- PlexusDxfrom $99/moSema. $99 · Tirz. $129None on file
- MEDGmfrom $169/moSema. $169 · Tirz. $269None on file
- DirectMedsfrom $249/moSema. $249 · Tirz. $3991 on file
- GoodLife Healthfrom $299/mo + drugMembership; brand-name drug billed separatelyNone on file
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Reference notes
Mochi Health: key questions answered
- Is Mochi Health (joinmochi.com) legit or a scam? What does the public record show?
- Yes. Mochi Health (joinmochi.com) is an active, operating US weight-loss telehealth company. It offers both compounded GLP-1 formulations and FDA-approved brand-name drugs at distinct price points. Disclosed or linked fulfillment pharmacies on record include Aequita Pharmacy. Our regulatory sweep matched 3 primary-sourced regulatory or legal actions on file: Eli Lilly sued Mochi Health Corp. in the Northern District of California on 23 April 2025 (No. 3:25-cv-03534) over compounded tirzepatide combined with additives including niacinamide, pyridoxine and glycine. In October 2025 the court granted Mochi's motion to dismiss with leave to amend, holding Lilly had not established standing on reputational harm alone; Novo Nordisk sued Mochi Health Corp. and its affiliated medical practices in the Northern District of California on 4 August 2025 (No. 5:25-cv-06563), alleging false advertising and unlawful mass compounding of semaglutide, including converting standard doses to non-standard ones and adding vitamin B12; allegations unproven; The Washington State Pharmacy Quality Assurance Commission issued a Limited Stop Service order on 13 March 2025 against Aequita Pharmacy LLC of Kirkland, Washington — reported to compound for Mochi Health — barring it from compounding or dispensing compounded products in the state, citing untrained and unqualified staff performing sterile compounding, inadequate supervision, and failure to follow sterile compounding procedures.
- Does Mochi Health sell compounded or FDA-approved weight loss medication?
- Compounded and branded. Supplies both compounded medication and FDA-approved branded drugs, usually at very different prices. Check which one a quoted price refers to. Specifically named on joinmochi.com: compounded semaglutide, compounded tirzepatide, Zepbound, Mounjaro.
- What are Mochi Health weight loss pricing, hidden fees, and cancellation terms?
- Mochi Health (joinmochi.com) publishes weight-loss plans starting at $79 per month, with the medication itself billed separately at the pharmacy, alongside a promotional or bundle rate of $49. Contract and billing terms: Health membership without qualifying insurance: $79/month, or $49/month for as long as you stay on a 12-month plan; on 30 Oct 2026 new subscribers on the 1-month plan were offered a $0 first month (then $79/month). Insurance plan membership from $17/month. Medication is self-pay and billed separately (branded Zepbound from $299, Wegovy from $199, Foundayo from $149 as listed); lab panels from $26. Operated by Mochi Health Corp. (joinmochi.com). Compounded semaglutide is $99/month ($60/month on select multi-month promos) and compounded tirzepatide is $199/month ($90/month on select promos) billed on top of the mandatory $79/month membership ($139–$178/month combined floor). Mochi faces a December 2024 Eli Lilly federal lawsuit (3:24-cv-09313) alleging it routed prescriptions through tiny-volume compounder Aequita Pharmacy and added unstudied vitamins to claim personalized dosing, and Washington State DOH restricted Aequita Pharmacy’s license in March 2025 over sterile compounding violations. No FDA warning letter directly naming Mochi Health Corp. was found.
- What compounding or fulfillment pharmacy does Mochi Health use?
- Mochi Health (joinmochi.com) names or is linked in primary records to the following fulfillment and 503A/503B compounding pharmacies: Aequita Pharmacy. Because telehealth platforms route prescriptions by state licensure, stock, and dosage, the specific dispensing pharmacy can vary by order; the pharmacy name and address printed on your prescription vial label is the authoritative record of who compounded or dispensed it.
- Are there FDA warning letters, lawsuits, or regulatory complaints against Mochi Health?
- Yes. We hold 3 primary-sourced regulatory or legal actions on record involving Mochi Health (joinmochi.com): Eli Lilly sued Mochi Health Corp. in the Northern District of California on 23 April 2025 (No. 3:25-cv-03534) over compounded tirzepatide combined with additives including niacinamide, pyridoxine and glycine. In October 2025 the court granted Mochi's motion to dismiss with leave to amend, holding Lilly had not established standing on reputational harm alone; Novo Nordisk sued Mochi Health Corp. and its affiliated medical practices in the Northern District of California on 4 August 2025 (No. 5:25-cv-06563), alleging false advertising and unlawful mass compounding of semaglutide, including converting standard doses to non-standard ones and adding vitamin B12; allegations unproven; The Washington State Pharmacy Quality Assurance Commission issued a Limited Stop Service order on 13 March 2025 against Aequita Pharmacy LLC of Kirkland, Washington — reported to compound for Mochi Health — barring it from compounding or dispensing compounded products in the state, citing untrained and unqualified staff performing sterile compounding, inadequate supervision, and failure to follow sterile compounding procedures. Every entry links directly to the primary FDA, NAD, or court document on this page. Separately from regulatory enforcement, our file notes 1 other sourced signal: BBB rating A but not accredited, with 1,378 complaints; themes include membership and medication subscriptions having to be cancelled separately, charges continuing after cancellation, and medication arriving heat-damaged.